Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17. - Wikidata - wikimedia - TriplyDB

Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.

Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.

http://www.wikidata.org/entity/Q36121354

about

Role of Microbial Modulation in Management of Atopic Dermatitis in Children.Biphasic influence of Staphylococcus aureus on human epidermal tight junctions.Tight junctions in skin inflammation.Current insights into the role of human β-defensins in atopic dermatitis.Esophageal and Small Intestinal Mucosal Integrity in Eosinophilic Esophagitis and Response to an Elemental Diet Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models.The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.Atopic Dermatitis: Pathophysiology.Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression.The Initiation of Th2 Immunity Towards Food Allergens.

P2860

Q38632479-CBFB99E6-2ECC-40F3-B848-B6B37361E918 Q38696206-ADA3B917-0F56-41CD-BAAE-9A05E1D61CF1 Q39010646-BA57AFBC-9360-4AE6-A03C-AE8966C50817 Q39435059-A4FBC0BA-BD8C-41F9-9B7F-4D04E189BB62 Q41126753-11A15704-B86D-49CB-95BE-6BD4FE1A7616 Q41717499-B21284AE-55E1-496B-BBC2-05F6905C236A Q47144191-A0F086C5-4B30-4C73-86E1-1D70E4A4455E Q47758483-94A7F18E-60FC-4119-8AAE-C9F0FCB42CB7 Q47829287-EB4499C9-31FE-42DE-A985-C9A2FE436743 Q50435670-DB5409D0-B694-4995-B95D-2C0C79FE69E5 Q52608972-47540EE2-8C17-400A-88FB-7AE3B3BB9A80 Q55108860-64D728D8-C5C5-436D-813D-AFE29C91E528

P2860

Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.

http://www.wikidata.org/entity/Q36121354

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@ast

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@en

type

label

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@ast

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@en

prefLabel

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@ast

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@en

P1433

Q36121354-8764D8C5-1600-465E-AE6C-AB988CCBB952

P1476

Q36121354-60B8D9C9-32CB-4CA4-ABE2-1CC2FDC0CAF8

P2093

Q36121354-39C61DF8-E144-48B4-843A-B9DA3F86BDA3

Q36121354-3CC8C412-360F-4D6A-BF1A-3734E0660CC2

Q36121354-407C9552-E29F-4214-BDC5-15811FEDB593

Q36121354-4338A0D7-FF94-459D-A252-DDB12504EC8C

P2860

Q36121354-1D49D214-CB2C-4556-BB3F-E970012CB8D0

Q36121354-1E9F8887-98C5-4822-B8F9-A0D9A418F4DC

Q36121354-20314895-CD4C-4373-B9A0-4B6C655F1128

Q36121354-2C844C34-6F5B-4DD9-8342-6B1EF9C30C42

Q36121354-2D1D5407-2EE1-4F7E-A7A6-674F56C4DBE4

Q36121354-43C6814B-BE13-48B8-96F3-7AE8BB4CC114

Q36121354-54E5C14D-B043-43BB-89BC-BEA296A8A4E1

Q36121354-59904692-C139-4FA1-9698-A2EC8540EFD5

Q36121354-5F9B3924-F0C2-42B0-ABB1-9DE2229233B3

Q36121354-5FA1ACA7-1A89-471E-AC0E-EF933AC8538E

P304

Q36121354-E48BCD12-D881-47B0-8618-CFEFF62F4470

P31

Q36121354-8D689271-8A9C-484C-AEAD-424E781C44EE

P356

Q36121354-71017BE4-361E-4D3D-B95E-3BBC468E61B1

P407

Q36121354-D8B951EC-D4BD-420E-9E48-17EE92CDCC42

P433

Q36121354-65688C6B-2911-4866-9A31-9D44DC1BC823

P478

Q36121354-F4A3B739-24E1-4FE5-8774-6FB8F125C071

P50

Q36121354-1A634F1A-515E-41A9-892D-44706D018450

P577

Q36121354-011361D4-3062-447B-BD56-7E0D034A38B0

P698

Q36121354-1651DE9D-D62A-44B3-9A65-022CAB60CCF2

P932

Q36121354-64CB181F-1C16-429E-A96A-8382EC042662

P356

JOURNAL.PONE.0161759

P1433

P1476

Impaired Tight Junctions in At ...... l Treated with Interleukin-17.

@en

P2093

Ayumi Kusaka-Kikushima

http://www.w3.org/2001/XMLSchema#string

Megumi Tobiishi

http://www.w3.org/2001/XMLSchema#string

Takuo Yuki

http://www.w3.org/2001/XMLSchema#string

Yukiko Ota

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes

Scratching the surface of skin development

Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermis

Organization and formation of the tight junction system in human epidermis and cultured keratinocytes

Multifunctional strands in tight junctions

Filaggrin in the frontline: role in skin barrier function and disease

Mammalian occludin in epithelial cells: its expression and subcellular distribution

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice

External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers

P304

e0161759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0161759

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27588419

http://www.w3.org/2001/XMLSchema#string

P932

5010286

http://www.w3.org/2001/XMLSchema#string